Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Arizmendi JM"'
Autor:
Ramirez J, Lectez B, Osinalde N, Sivá M, Elu N, Aloria K, Procházková M, Perez C, Martínez-Hernández J, Barrio R, Grantz Šašková K, Arizmendi JM, Mayor U
Angelman syndrome is a complex neurodevelopmental disorder caused by the lack of function in the brain of a single gene, UBE3A. The E3 ligase coded by this gene is known to build K48-linked ubiquitin chains, a modification historically considered to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::45acde6846c8fd13100d8fbe66c4ff86
https://zenodo.org/record/2636799
https://zenodo.org/record/2636799
Autor:
Colomé N; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain., Abian J; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, 08036 Barcelona, Spain., Aloria K; ProteoRed-ISCIII, Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), Leioa, Spain., Arizmendi JM; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Barceló-Batllori S; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Braga-Lagache S; Department for BioMedical Research (DBMR), Proteomics and Mass Spectrometry Core Facility, University of Bern, CH-3010 Bern, Switzerland., Burlet-Schiltz O; Proteomics and Mass Spectrometry of Biomolecules, Proteomics Infrastructure of Toulouse, Proteomics French Infrastructure, ProFI. Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, UPS, CNRS, Toulouse, France., Carrascal M; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, 08036 Barcelona, Spain., Casal JI; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain., Chicano-Gálvez E; ProteoRed-ISCIII, Proteomics Unit, IMIBIC/UCO/HURS, IMIBIC Building Fl.3, 14004 Córdoba, Spain., Chiva C; Proteomics Unit, Center for Genomics Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; ProteoRed ISCIII, Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain., Clemente LF; ProteoRed-ISCIII, Proteomics Unit, Complutense University, 28040 Madrid, Spain., Elortza F; ProteoRed-ISCIII, CIC bioGUNE, Proteomics Platform, Basque Research & Technology Alliance (BRTA), CIBERehd,Bizkaia Science and Technology Park, 48160 Derio, Spain., Estanyol JM; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, 08036 Barcelona, Spain., Fernandez-Irigoyen J; Proteored-ISCIII. Proteomics Unit, Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, 31008 Pamplona, Spain., Fernández-Puente P; Grupo de Investigación de Reumatología (GIR), Agrupación CICA-INIBIC, Universidad de A Coruña, A Coruña, Spain., Fidalgo MJ; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, 08036 Barcelona, Spain., Froment C; Proteomics and Mass Spectrometry of Biomolecules, Proteomics Infrastructure of Toulouse, Proteomics French Infrastructure, ProFI. Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, UPS, CNRS, Toulouse, France., Fuentes M; Department of Medicine and General Cytometry Service-Nucleus, Proteomics Unit, CIBERONC, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), Universidad de Salamanca, Spain., Fuentes-Almagro C; Proteomics Unit, SCAI, University of Córdoba, Ramón y Cajal Building, Rabanales Campus, 14071, Córdoba, Spain., Gay M; ProteoRed-ISCIII, Institute for Research in Biomedicine (IRB Barcelona), BIST (The Barcelona Institute of Science and Technology), Baldiri i Reixac 10, 08028 Barcelona, Spain., Hainard A; Proteomics Core Facility, CMU, University of Geneva, Switzerland., Heller M; Department for BioMedical Research (DBMR), Proteomics and Mass Spectrometry Core Facility, University of Bern, CH-3010 Bern, Switzerland., Hernández ML; ProteoRed-ISCIII, Proteomics Unit, Complutense University, 28040 Madrid, Spain., Ibarrola N; ProteoRed-ISCIII, Proteomics Unit. Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), Universidad de Salamanca-CSIC, Salamanca, Spain., Iloro I; ProteoRed-ISCIII, CIC bioGUNE, Proteomics Platform, Basque Research & Technology Alliance (BRTA), CIBERehd,Bizkaia Science and Technology Park, 48160 Derio, Spain., Kieselbach T; Umeå University, Department of Chemistry, 90187, Umeå, Sweden., Lario A; ProteoRed-ISCIII, IPBLN -CSIC, 18016 Granada, Spain., Locard-Paulet M; Proteomics and Mass Spectrometry of Biomolecules, Proteomics Infrastructure of Toulouse, Proteomics French Infrastructure, ProFI. Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, UPS, CNRS, Toulouse, France., Marina-Ramírez A; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain., Martín L; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain., Morato-López E; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain., Muñoz J; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Navajas R; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), 28049, Madrid, Spain., Odena MA; ProteoRed-ISCIII, Proteomics Platform, Barcelona Science Park, 08028, Barcelona, Spain., Odriozola L; ProteoRed-ISCIII, CIMA, University of Navarra, 31008, Pamplona, Spain., de Oliveira E; ProteoRed-ISCIII, Proteomics Platform, Barcelona Science Park, 08028, Barcelona, Spain., Paradela A; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), 28049, Madrid, Spain., Pasquarello C; Proteomics Core Facility, CMU, University of Geneva, Switzerland., de Los Rios V; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain., Ruiz-Romero C; Grupo de Investigación de Reumatología (GIR) - ProteoRed-ISCIII, Unidad de Proteómica, INIBIC-Complejo Hospitalario Universitario de A Coruña, SERGAS, A Coruña, Spain., Sabidó E; Proteomics Unit, Center for Genomics Regulation, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain; ProteoRed ISCIII, Proteomics Unit, Universitat Pompeu Fabra, Barcelona, Spain., Sánchez Del Pino M; Biotechnology and Biomedicine Interdisciplinary Research Unit (ERI BIOTECMED), University of Valencia, 46100 Burjassot, Spain., Sancho J; ProteoRed-ISCIII, IPBLN -CSIC, 18016 Granada, Spain., Santamaría E; Proteored-ISCIII. Proteomics Unit, Clinical Neuroproteomics Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), IdiSNA, 31008 Pamplona, Spain., Schaeffer-Reiss C; Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000, Strasbourg, France., Schneider J; Laboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, 67000, Strasbourg, France., de la Torre C; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Valero ML; ProteoRed-ISCIII, Proteomics Unit, Central Service for Experimental Research (SCSIE), University of Valencia, 46100, Burjassot, Spain., Vilaseca M; ProteoRed-ISCIII, Institute for Research in Biomedicine (IRB Barcelona), BIST (The Barcelona Institute of Science and Technology), Baldiri i Reixac 10, 08028 Barcelona, Spain., Wu S; Agilent Technologies, Inc., Santa Clara, CA 95051, USA., Wu L; Agilent Technologies, Inc., Santa Clara, CA 95051, USA., Ximénez de Embún P; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Canals F; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain. Electronic address: fcanals@vhio.net., Corrales FJ; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), 28049, Madrid, Spain; ProteoRed-ISCIII, CIMA, University of Navarra, 31008, Pamplona, Spain. Electronic address: fcorrales@cnb.csic.es.
Publikováno v:
Journal of proteomics [J Proteomics] 2022 Jan 16; Vol. 251, pp. 104409. Date of Electronic Publication: 2021 Nov 07.
Autor:
Ramirez J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Prieto G; Department of Communications Engineering, University of the Basque Country (UPV/EHU), 48013 Bilbao, Spain., Olazabal-Herrero A; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Borràs E; Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain., Fernandez-Vigo E; Proteomics Unit, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain., Alduntzin U; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Osinalde N; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain., Beaskoetxea J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Lectez B; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Aloria K; Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Rodriguez JA; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Paradela A; Functional Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), ProteoRed-ISCIII, 28029 Madrid, Spain., Sabidó E; Center for Genomic Regulation, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain., Muñoz J; Proteomics Unit, Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain., Corrales F; Functional Proteomics Facility, Centro Nacional de Biotecnología (CNB-CSIC), ProteoRed-ISCIII, 28029 Madrid, Spain., Arizmendi JM; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Mayor U; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 May 03; Vol. 22 (9). Date of Electronic Publication: 2021 May 03.
Autor:
Mercado-Gómez M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Lopitz-Otsoa F; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Azkargorta M; Proteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), CIBERehd, ProteoRed-ISCII, 48160 Derio, Bizkaia, Spain., Serrano-Maciá M; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Lachiondo-Ortega S; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Goikoetxea-Usandizaga N; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Rodríguez-Agudo R; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Fernández-Ramos D; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain., Bizkarguenaga M; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Juan VG; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Lectez B; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Aloria K; Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Arizmendi JM; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Simon J; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Alonso C; OWL Metabolomics, 48610 Derio, Bizkaia, Spain., Lozano JJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Bioinformatics Platform, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 08036 Barcelona, Spain., Avila MA; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Hepatology Programme, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, 31008 Pamplona, Spain., Banales JM; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Hepatology and Gastroenterology, Biodonostia Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), 20014 San Sebastian, Spain.; Ikerbasque, Basque Foundation for Science, 48009 Bilbao, Bizkaia, Spain., Marin JJG; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Experimental Hepatology and Drug Targeting (HEVEPHARM), IBSAL, University of Salamanca, 37007 Salamanca, Spain., Beraza N; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Mato JM; Precision Medicine and Metabolism Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Elortza F; Proteomics Platform, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), CIBERehd, ProteoRed-ISCII, 48160 Derio, Bizkaia, Spain., Barrio R; Ubiquitin-likes and Development Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Sutherland JD; Ubiquitin-likes and Development Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain., Mayor U; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Ikerbasque, Basque Foundation for Science, 48009 Bilbao, Bizkaia, Spain., Martínez-Chantar ML; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain., Delgado TC; Liver Disease Lab, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), 48160 Derio, Bizkaia, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 27; Vol. 21 (23). Date of Electronic Publication: 2020 Nov 27.
Autor:
Elu N; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Osinalde N; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain., Beaskoetxea J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Ramirez J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Lectez B; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Aloria K; Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), Leioa, Spain., Rodriguez JA; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain., Arizmendi JM; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain., Mayor U; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.; Ikerbasque - Basque Foundation for Science, Bilbao, Spain.
Publikováno v:
Frontiers in physiology [Front Physiol] 2019 May 03; Vol. 10, pp. 534. Date of Electronic Publication: 2019 May 03 (Print Publication: 2019).
Autor:
Ramirez J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Lectez B; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Osinalde N; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (UPV/EHU), 01006 Vitoria-Gasteiz, Spain., Sivá M; Department of Genetics and Microbiology, Charles University, 12843 Prague, Czech Republic.; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic.; First Faculty of Medicine, Charles University, 12108 Prague, Czech Republic., Elu N; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Aloria K; Proteomics Core Facility-SGIKER, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Procházková M; Czech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases, Division BIOCEV, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic., Perez C; Functional Genomics Unit, CIC bioGUNE, 48160 Derio, Spain., Martínez-Hernández J; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain., Barrio R; Functional Genomics Unit, CIC bioGUNE, 48160 Derio, Spain., Šašková KG; Department of Genetics and Microbiology, Charles University, 12843 Prague, Czech Republic.; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, 16610 Prague, Czech Republic., Arizmendi JM; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain., Mayor U; Department of Biochemistry and Molecular Biology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.; Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.
Publikováno v:
Human molecular genetics [Hum Mol Genet] 2018 Jun 01; Vol. 27 (11), pp. 1955-1971.
Autor:
Martinez A; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV-EHU), 48940 Leioa, Spain., Ramirez J; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV-EHU), 48940 Leioa, Spain., Osinalde N; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV-EHU), 01006 Vitoria-Gasteiz, Spain., Arizmendi JM; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV-EHU), 48940 Leioa, Spain., Mayor U; Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV-EHU), 48940 Leioa, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
Publikováno v:
BioMed research international [Biomed Res Int] 2018 Mar 06; Vol. 2018, pp. 3180413. Date of Electronic Publication: 2018 Mar 06 (Print Publication: 2018).
Autor:
Segura V; Proteomics, Genomics and Bioinformatics Unit, Center for Applied Medical Research, University of Navarra, Pamplona 31008, Spain. vsegura@unav.es., Valero ML; Proteomics Unit; Central Service for Experimental Research (SCSIE), University of Valencia. Dr Moliner 50, 46100 Burjassot, Spain. mluz.valero@uv.es., Cantero L; Proteomics Unit; Central Service for Experimental Research (SCSIE), University of Valencia. Dr Moliner 50, 46100 Burjassot, Spain. laura.cantero@uv.es., Muñoz J; Spanish National Cancer Research Centre (CNIO), Melchor Férnandez Almagro, 3, 28029 Madrid. Spain. jmunozpe@cnio.es., Zarzuela E; Spanish National Cancer Research Centre (CNIO), Melchor Férnandez Almagro, 3, 28029 Madrid. Spain. ezarzuela@cnio.es., García F; Spanish National Cancer Research Centre (CNIO), Melchor Férnandez Almagro, 3, 28029 Madrid. Spain. fgarcia@cnio.es., Aloria K; Proteomics Core Facility-SGIKER, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain. kerman.aloria@ehu.eus., Beaskoetxea J; Department of Biochemistry and Molecular Biology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain. javier.beaskoetxea@ehu.eus., Arizmendi JM; Department of Biochemistry and Molecular Biology, University of the Basque Country, UPV/EHU, 48940 Leioa, Spain. jm.arizmendi@ehu.eus., Navajas R; Proteomics Unit, Centro Nacional de Biotecnología-CSIC, Darwin 3, 28049 Madrid, Spain. rnavajas@cnb.csic.es., Paradela A; Proteomics Unit, Centro Nacional de Biotecnología-CSIC, Darwin 3, 28049 Madrid, Spain. alberto.paradela@cnb.csic.es., Díez P; Department of Medicine and General Cytometry Service-Nucleus, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. pauladg@usal.es.; Proteomics Unit. Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. pauladg@usal.es., Dégano RM; Department of Medicine and General Cytometry Service-Nucleus, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. agarin@unav.es.; Proteomics Unit. Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. agarin@unav.es., Fuentes M; Department of Medicine and General Cytometry Service-Nucleus, Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. mfuentes@usal.es.; Proteomics Unit. Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain. mfuentes@usal.es., Orfao A; Cancer Research Center. University of Salamanca-CSIC, IBSAL, 37007 Salamanca, Spain. orfao@usal.es., Montero AG; Spanish National DNA Bank Carlos III, University of Salamanca, 37007 Salamanca, Spain. angarmon@usal.es., Garin-Muga A; Proteomics, Genomics and Bioinformatics Unit, Center for Applied Medical Research, University of Navarra, Pamplona 31008, Spain. fcorrales@cnb.csic.es., Corrales FJ; Proteomics Unit, Centro Nacional de Biotecnología-CSIC, Darwin 3, 28049 Madrid, Spain. romade@usal.es., Pino MMSD; Department of Biochemistry and Molecular Biology, University of Valencia. Dr Moliner 50, 46100 Burjassot, Spain. sandelpi@uv.es.; Biotechnology and Biomedicine Interdisciplinary Research Unit (ERI BIOTECMED), University of Valencia. Dr Moliner 50, 46100 Burjassot, Spain. sandelpi@uv.es.
Publikováno v:
Proteomes [Proteomes] 2018 Feb 05; Vol. 6 (1). Date of Electronic Publication: 2018 Feb 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vialas V; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain., Colomé-Calls N; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain., Abian J; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, Barcelona 08036, Spain., Aloria K; Department of Biochemistry and Molecular Biology, University of the Basque Country-UPV/EHU, Leioa 48940, Spain., Alvarez-Llamas G; ProteoRed-ISCIII, IIS Fundación Jimenez Diaz, Madrid, Spain., Antúnez O; ProteoRed-ISCIII, SCSIE Universitat de Valencia, Burjassot 46100, Spain., Arizmendi JM; ProteoRed-ISCIII, University of the Basque Country-UPV/EHU, Leioa 48940, Spain., Azkargorta M; ProteoRed-ISCIII, CIC bioGUNE, Science and Technology Park of Bizkaia, Derio, Spain., Barceló-Batllori S; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Barderas MG; ProteoRed-ISCIII, Hospital Nacional de Parapléjicos-SESCAM, Toledo, Spain., Blanco F; ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña 15006, Spain., Casal JI; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain., Casas V; ProteoRed-ISCIII, Instituto de Investigaciones Biomédicas de Barcelona, IIBB-CSIC/IDIBAPS, Barcelona 08036, Spain., de la Torre C; ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Chicano-Gálvez E; ProteoRed-ISCIII, Maimonides Institute for Biomedical Research and Universidad de Córdoba, Córdoba 14004, Spain., Elortza F; ProteoRed-ISCIII, CIC bioGUNE, Science and Technology Park of Bizkaia, Derio, Spain., Espadas G; ProteoRed-ISCIII, Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona 08003, Spain., Estanyol JM; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, Barcelona 08036, Spain., Fernandez-Irigoyen J; ProteoRed-ISCIII, Navarrabiomed Biomedical Research Center-IdiSNa, Pamplona, Spain., Fernandez-Puente P; ProteoRed-ISCIII, INIBIC-CHUAC, A Coruña 15006, Spain., Fidalgo MJ; ProteoRed-ISCIII, Scientific and Technological Centers (CCiTUB), University of Barcelona, Barcelona 08036, Spain., Fuentes M; ProteoRed-ISCIII, Cancer Research Center, University of Salamanca-CSIC, IBSAL, Salamanca 37007, Spain., Gay M; ProteoRed-ISCIII, Institute for Research in Biomedicine (IRB Barcelona), Barcelona 08028, Spain., Gil C; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain., Hainard A; Proteomics Core Facility CMU, University of Geneva, Geneva, Switzerland., Hernaez ML; ProteoRed-ISCIII, Universidad Complutense de Madrid, Madrid 28040, Spain., Ibarrola N; ProteoRed-ISCIII, Cancer Research Center, University of Salamanca-CSIC, IBSAL, Salamanca 37007, Spain., Kopylov AT; Orekhovich Institute of Biomedical Chemistry RAMS, Moscow 119121, Russian Federation., Lario A; ProteoRed-ISCIII, IPBLN (CSIC), Armilla, Granada, Spain., Lopez JA; ProteoRed-ISCIII, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain., López-Lucendo M; ProteoRed-ISCIII, Centro de Investigaciones Biológicas-CSIC, Madrid 28040, Spain., Marcilla M; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), Madrid 28049, Spain., Marina-Ramírez A; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain., Marko-Varga G; Centre of Excellence in Biological and Medical Mass spectrometry, Lund University, Lund, Sweden., Martín L; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain., Mora MI; ProteoRed-ISCIII, CIMA, University of Navarra, Pamplona 31008, Spain., Morato-López E; ProteoRed-ISCIII, CBM Severo Ochoa (CSIC-UAM), Madrid 28049, Spain., Muñoz J; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Odena MA; ProteoRed-ISCIII, Barcelona Science Park, Barcelona 08028, Spain., de Oliveira E; ProteoRed-ISCIII, Barcelona Science Park, Barcelona 08028, Spain., Orera I; ProteoRed-ISCIII, Instituto Aragonés de Ciencias de la Salud, Zaragoza 50009, Spain., Ortea I; ProteoRed-ISCIII, Maimonides Institute for Biomedical Research and Universidad de Córdoba, Córdoba 14004, Spain., Pasquarello C; Proteomics Core Facility CMU, University of Geneva, Geneva, Switzerland., Ray KB; MilliporeSigma, St. Louis, MO, USA., Rezeli M; Centre of Excellence in Biological and Medical Mass spectrometry, Lund University, Lund, Sweden., Ruppen I; ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain., Sabidó E; ProteoRed-ISCIII, Centre de Regulació Genòmica, Universitat Pompeu Fabra, Barcelona 08003, Spain., Del Pino MMS; Departament de Bioquímica i Biologia Molecular, Universitat de Valencia, Burjassot 46100, Spain., Sancho J; ProteoRed-ISCIII, IPBLN (CSIC), Armilla, Granada, Spain., Santamaría E; ProteoRed-ISCIII, Navarrabiomed Biomedical Research Center-IdiSNa, Pamplona, Spain., Vazquez J; ProteoRed-ISCIII, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid 28029, Spain., Vilaseca M; ProteoRed-ISCIII, Institute for Research in Biomedicine (IRB Barcelona), Barcelona 08028, Spain., Vivanco F; ProteoRed-ISCIII, IIS Fundación Jimenez Diaz, Madrid, Spain., Walters JJ; MilliporeSigma, St. Louis, MO, USA., Zgoda VG; Orekhovich Institute of Biomedical Chemistry RAMS, Moscow 119121, Russian Federation., Corrales FJ; ProteoRed-ISCIII, CIMA, University of Navarra, Pamplona 31008, Spain., Canals F; ProteoRed-ISCIII, Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain. Electronic address: fcanals@vhio.net., Paradela A; ProteoRed-ISCIII, Centro Nacional de Biotecnologia (CSIC), Madrid 28049, Spain. Electronic address: alberto.paradela@cnb.csic.es.
Publikováno v:
Journal of proteomics [J Proteomics] 2017 Jan 30; Vol. 152, pp. 138-149. Date of Electronic Publication: 2016 Oct 29.